Forschungsprojekte (Drittmittel)


New nanotherapy research for inflammatory bowel diseases

The NEW DEAL project aims to develop a highly selective and local therapy with an improved efficacy and safety profile for IBD patients. This treatment might be an alternative to the existing therapies. In this project the HZI will contribute with its expert’s knowledge on advanced coculture models of the intestinal barrier and expertise in siRNA delivery.


Beteiligte Gruppen


Brigitta Loretz

DruckenPer Mail versendenTeilen